Ingram Douglas S
- SEC CIK
- 0001190644
No open-market purchases or sales filed in the past year.
Current role at each company
- RLAY Relay Therapeutics, Inc.Directoras of Jun 10, 2026
- ARWR Arrowhead Pharmaceuticals, Inc.Directoras of Dec 18, 2025
- SRPT Sarepta Therapeutics, Inc.Chief Executive Officeras of Dec 9, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ingram Douglas S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SRPT Sarepta Therapeutics, Inc.
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2023 (view filing) | Nov 3 | 3 days | Ingram Douglas SPresident & CEO | PPurchase | +25.2K | $79.36 | +$2.00M | +6.9%390.3K after | 4 lots |
| Nov 17, 2021 (view filing) | Nov 17 | Same day | Ingram Douglas SPresident & CEO | PPurchase | +25.0K | $79.94 | +$2.00M | +7.4%365.1K after |